Nanmu Yang

机构：Henan Cancer Hospital

发表论文 23 篇 · 总被引 431 次 · h-index 7

代表论文

• Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer (2024 · Cancer Cell · 被引 132)
• HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3‐mediated m6A modification of HIF‐1α (2020 · Journal of Cellular Physiology · 被引 117)
• Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling (2014 · Pharmacological Reports · 被引 53)
• Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling (2016 · Oncology Letters · 被引 39)
• CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma (2024 · Cancer Letters · 被引 36)
• miR-96 exerts carcinogenic effect by activating AKT/GSK-3β/β-catenin signaling pathway through targeting inhibition of FOXO1 in hepatocellular carcinoma (2019 · Cancer Cell International · 被引 27)